Health Care & Life Sciences » Pharmaceuticals | Stallergenes Greer PLC

Stallergenes Greer PLC | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
112,453.00
145,791.00
150,183.00
71,262.00
51,519.00
Total Accounts Receivable
44,470.00
47,105.00
57,805.00
63,758.00
62,012.00
Inventories
32,210.00
35,556.00
59,362.00
63,786.00
56,793.00
Other Current Assets
974.00
2,557.00
3,001.00
2,888.00
3,751.00
Total Current Assets
190,107.00
231,009.00
270,351.00
201,694.00
174,075.00
Net Property, Plant & Equipment
62,126.00
58,154.00
78,059.00
80,304.00
69,138.00
Total Investments and Advances
2,790.00
11,303.00
17,073.00
-
134.00
Long-Term Note Receivable
587.00
1,295.00
3,269.00
6,011.00
3,823.00
Intangible Assets
42,997.00
53,827.00
312,560.00
306,978.00
266,100.00
Other Assets
-
-
-
-
237.00
Total Assets
300,131.00
356,981.00
685,759.00
630,364.00
540,261.00
ST Debt & Current Portion LT Debt
3,709.00
-
17,669.00
16,366.00
12,204.00
Accounts Payable
18,912.00
17,948.00
27,612.00
26,658.00
19,793.00
Income Tax Payable
687.00
2,524.00
1,549.00
1,217.00
1,313.00
Other Current Liabilities
42,522.00
51,628.00
67,165.00
66,272.00
43,068.00
Total Current Liabilities
65,830.00
72,100.00
113,995.00
110,513.00
76,378.00
Long-Term Debt
-
-
-
6,753.00
6,318.00
Provision for Risks & Charges
2,894.00
4,891.00
6,091.00
6,139.00
3,956.00
Deferred Taxes
957.00
1,163.00
21,245.00
17,627.00
20,471.00
Total Liabilities
71,205.00
79,547.00
145,778.00
141,155.00
92,935.00
Common Equity (Total)
228,926.00
277,434.00
539,981.00
489,209.00
447,326.00
Total Shareholders' Equity
228,926.00
277,434.00
539,981.00
489,209.00
447,326.00
Total Equity
228,926.00
277,434.00
539,981.00
489,209.00
447,326.00
Liabilities & Shareholders' Equity
300,131.00
356,981.00
685,759.00
630,364.00
540,261.00

About Stallergenes Greer

View Profile
Address
40 Bernard Street
London Greater London WC1N 1LE
United Kingdom
Employees -
Website http://stallergenes.co.uk
Updated 09/14/2018
Stallergenes Greer Plc is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. It operates through the following geigraphical segments: Southern Europe; Northern and Central Europe; Internation Markets; and United States.